Influence of anemia for cardiovascular and renal events in patients with type 2 diabetes: a prospective observational study

Influence of anemia for cardiovascular and renal events in patients with type 2 diabetes: a prospective observational study - Influence of anemia for cardiovascular and renal events in patients with type 2 diabetes: a prospective observational study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047632

Enrollment

700

Registered

2022-05-01

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with type 2 diabetes who were evaluated hemoglobin, renal function and urinary albumin excretion

Exclusion criteria

Exclusion criteria: patients using SGLT2 inhibitors or GLP-1 receptor agonists

Design outcomes

Primary

Measure	Time frame
Renal events (ESKD or decline in eGFR by 30% or more from the start of observation).	—

Secondary

Measure	Time frame
Cardiovascular events (cardiovascular death, nonfatal myocardial infarction, heart failure, or nonfatal stroke)	—

Countries

Japan

Contacts

Public ContactHiroyuki Ito

Edogawa Hospital Department of Diabetes, Metabolism and Kidney Disease

ito@edogawa.or.jp03-3673-1221

Outcome results